Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ole K. Østergård, Adriana del Palacio-Gonzalez, Kristine K. Nilsson & Mads U. Pedersen. (2021) The Partners for Change Outcome Management System in the psychotherapeutic treatment of cannabis use: a pilot effectiveness randomized clinical trial. Nordic Journal of Psychiatry 75:8, pages 633-640.
Read now
Read now
Articles from other publishers (13)
Oskar Hougaard Jefsen, Annette Erlangsen, Merete Nordentoft & Carsten Hjorthøj. (2023) Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder. JAMA Psychiatry 80:8, pages 803.
Crossref
Crossref
Llewellyn Mills, Adrian Dunlop, Mark Montebello, Jan Copeland, Raimondo Bruno, Meryem Jefferies, Iain Mcgregor & Nicholas Lintzeris. (2022) Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Substance Abuse Treatment, Prevention, and Policy 17:1.
Crossref
Crossref
Sacha Parada, Eve Legrand, Elsa Taschini, Xavier Laqueille & Jean-François Verlhiac. (2022) Dweck’s Mindset Theory Applied to Addictions: a Scoping Review. Current Addiction Reports 9:3, pages 133-150.
Crossref
Crossref
. 2022. Psicose e drogas: estado mental de risco e primeiro episódio psicótico em usuários de maconha. Psicose e drogas: estado mental de risco e primeiro episódio psicótico em usuários de maconha.
Robert S. Stephens, Robrina Walker, Stephanie A. Fearer & Roger A. Roffman. (2021) Reaching nontreatment-seeking cannabis users: Testing an extended marijuana check-up intervention. Journal of Substance Abuse Treatment 125, pages 108269.
Crossref
Crossref
Robert S. Stephens, Robrina Walker, Josephine DeMarce, Brian E. Lozano, Jared Rowland, Denise Walker & Roger A. Roffman. (2020) Treating cannabis use disorder: Exploring a treatment as needed model with 34-month follow-up. Journal of Substance Abuse Treatment 117, pages 108088.
Crossref
Crossref
Nicholas Lintzeris, Llewellyn Mills, Adrian Dunlop, Jan Copeland, Iain Mcgregor, Raimondo Bruno, Adrienne Kirby, Mark Montebello, Michelle Hall, Meryem Jefferies, Richard Kevin & Anjali Bhardwaj. (2020) Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial. Drug and Alcohol Dependence 215, pages 108220.
Crossref
Crossref
Ovidiu Tatar, Gabriel Bastien, Amal Abdel-Baki, Christophe Huỳnh & Didier Jutras-Aswad. (2020) A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis. Psychiatry Research 288, pages 112940.
Crossref
Crossref
Esme Fuller-Thomson, Janany Jayanthikumar, Melissa L. Redmond & Senyo Agbeyaka. (2020) Is Recovery from Cannabis Dependence Possible? Factors that Help or Hinder Recovery in a National Sample of Canadians with a History of Cannabis Dependence. Advances in Preventive Medicine 2020, pages 1-9.
Crossref
Crossref
Sameer Imtiaz, Michael Roerecke, Paul Kurdyak, Andriy V. Samokhvalov, Omer S. M. Hasan & Jürgen Rehm. (2020) Brief Interventions for Cannabis Use in Healthcare Settings: Systematic Review and Meta-analyses of Randomized Trials. Journal of Addiction Medicine 14:1, pages 78-88.
Crossref
Crossref
Benedikt Fischer, Monica Malta, Guilherme Messas & Marcelo Ribeiro. (2019) Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil. Brazilian Journal of Psychiatry 41:6, pages 550-555.
Crossref
Crossref
Helen Frost, Pauline Campbell, Margaret Maxwell, Ronan E. O’Carroll, Stephan U. Dombrowski, Brian Williams, Helen Cheyne, Emma Coles & Alex Pollock. (2018) Effectiveness of Motivational Interviewing on adult behaviour change in health and social care settings: A systematic review of reviews. PLOS ONE 13:10, pages e0204890.
Crossref
Crossref
Maria Neumann, Gerhard Bühringer, Michael Höfler, Hans-Ulrich Wittchen & Eva Hoch. (2018) Is Cannabis Use Treatment Also Indicated for Patients with Low to Moderate Polysubstance Use. European Addiction Research 24:2, pages 79-87.
Crossref
Crossref